The InfectoGnostics research campus Jena has become a member of the BEAM (Biotech companies in Europe combating AntiMicrobial resistance) Alliance. The BEAM Alliance brings together more than 70 European small and medium-sized enterprises (SMEs) that are developing innovative solutions to tackle antimicrobial resistance (AMR).
By joining, InfectoGnostics actively contributes to the European dialogue on new diagnostic and therapeutic strategies against infectious diseases. The campus thus becomes part of a strong alliance advocating for improved framework conditions to develop and commercialize innovative solutions in the fight against multidrug-resistant pathogens.
The BEAM Alliance serves as an important voice towards policymakers, investors, and stakeholders in the healthcare sector, while also enhancing the international visibility of its members.